| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |